Literature DB >> 29200354

Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations.

Joshua A Barocas1, Jianing Wang2, Laura F White3, Abriana Tasillo4, Joshua A Salomon5, Kenneth A Freedberg6, Benjamin P Linas7.   

Abstract

In 2012 the Centers for Disease Control and Prevention recommended routine testing for hepatitis C for people born in the period 1945-65. Until now, the recommendation's impact on hepatitis C screening rates in the United States has not been fully understood. We used an interrupted time series with comparison group design to analyze hepatitis C screening rates in the period 2010-14 among 2.8 million commercially insured adults in the MarketScan database. Hepatitis C screening rates increased yearly between 2010 and 2014, from 1.65 to 2.59 per 100 person-years. A 49 percent increase in screening rates among people born during 1945-65 followed the release of the recommendation, but no such increase was observed among adults born after 1965. The effect among the target population was sustained, and by twenty-four months after the recommendation's release, screening rates had increased 106 percent. We conclude that the hepatitis C testing policy change resulted in significantly increased testing among the target population and may have decreased the magnitude of the hepatitis C epidemic.

Entities:  

Keywords:  Epidemiology; Medicine/Clinical Issues; Public Health

Mesh:

Year:  2017        PMID: 29200354      PMCID: PMC5721349          DOI: 10.1377/hlthaff.2017.0684

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   9.048


  37 in total

1.  Regional variations in HPV vaccination among 9-17 year old adolescent females from the BRFSS, 2008-2010.

Authors:  Jacqueline M Hirth; Mahbubur Rahman; Jennifer S Smith; Abbey B Berenson
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Toward a more accurate estimate of the prevalence of hepatitis C in the United States.

Authors:  Brian R Edlin; Benjamin J Eckhardt; Marla A Shu; Scott D Holmberg; Tracy Swan
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

3.  Recent Hepatitis C Virus Testing Patterns Among Baby Boomers.

Authors:  Ahmedin Jemal; Stacey A Fedewa
Journal:  Am J Prev Med       Date:  2017-03-08       Impact factor: 5.043

4.  Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008.

Authors:  Bryce D Smith; Geoff A Beckett; Anthony Yartel; Deborah Holtzman; Nita Patel; John W Ward
Journal:  Am J Public Health       Date:  2014-01-16       Impact factor: 9.308

5.  The Impact of Enhanced Screening and Treatment on Hepatitis C in the United States.

Authors:  David P Durham; Laura A Skrip; Robert Douglas Bruce; Silvia Vilarinho; Elamin H Elbasha; Alison P Galvani; Jeffrey P Townsend
Journal:  Clin Infect Dis       Date:  2015-11-30       Impact factor: 9.079

6.  Uptake of hepatitis C screening, characteristics of patients tested, and intervention costs in the BEST-C study.

Authors:  Joanne E Brady; Danielle K Liffmann; Anthony Yartel; Natalie Kil; Alex D Federman; Joseph Kannry; Cynthia Jordan; Omar I Massoud; David R Nerenz; Kimberly A Brown; Bryce D Smith; Claudia Vellozzi; David B Rein
Journal:  Hepatology       Date:  2016-11-25       Impact factor: 17.425

7.  Hepatitis C Antibody Testing in a Commercially Insured Population, 2005-2014.

Authors:  Cheryl J Isenhour; Susan H Hariri; Craig M Hales; Claudia J Vellozzi
Journal:  Am J Prev Med       Date:  2017-02-01       Impact factor: 5.043

8.  Disparities in hepatitis C testing in U.S. veterans born 1945-1965.

Authors:  Souvik Sarkar; Denise A Esserman; Melissa Skanderson; Forrest L Levin; Amy C Justice; Joseph K Lim
Journal:  J Hepatol       Date:  2016-04-27       Impact factor: 25.083

9.  Prevalence of hepatitis C virus infection among injection drug users in the United States, 1994-2004.

Authors:  Joseph J Amon; Richard S Garfein; Linda Ahdieh-Grant; Gregory L Armstrong; Lawrence J Ouellet; Mary H Latka; David Vlahov; Steffanie A Strathdee; Sharon M Hudson; Peter Kerndt; Don Des Jarlais; Ian T Williams
Journal:  Clin Infect Dis       Date:  2008-06-15       Impact factor: 9.079

10.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

View more
  22 in total

1.  Differential Impact of Age Among Liver Transplant Candidates With and Without Hepatocellular Carcinoma.

Authors:  Giuseppe Cullaro; Jessica B Rubin; Neil Mehta; Jennifer C Lai
Journal:  Liver Transpl       Date:  2019-11-20       Impact factor: 5.799

2.  Implementation and Preliminary Results of an Emergency Department Nontargeted, Opt-out Hepatitis C Virus Screening Program.

Authors:  Elissa M Schechter-Perkins; Nancy S Miller; Jon Hall; Joshua J Hartman; David H Dorfman; Chris Andry; Benjamin P Linas
Journal:  Acad Emerg Med       Date:  2018-07-20       Impact factor: 3.451

3.  Hepatitis C Management at Federally Qualified Health Centers during the Opioid Epidemic: A Cost-Effectiveness Study.

Authors:  Sabrina A Assoumou; Shayla Nolen; Liesl Hagan; Jianing Wang; Golnaz Eftekhari Yazdi; William W Thompson; Kenneth H Mayer; Jon Puro; Lin Zhu; Joshua A Salomon; Benjamin P Linas
Journal:  Am J Med       Date:  2020-06-27       Impact factor: 4.965

4.  The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care.

Authors:  Andrew D Schreiner; John Bian; Jingwen Zhang; Z Merle Haulsee; Justin Marsden; Valerie Durkalski-Mauldin; Patrick D Mauldin; William P Moran; Don C Rockey
Journal:  Am J Med       Date:  2019-07-29       Impact factor: 4.965

5.  The Cost of Hepatitis C Testing Strategies in Primary Care Patients with Abnormal Transaminases.

Authors:  Andrew D Schreiner; Don C Rockey; William P Moran
Journal:  J Gen Intern Med       Date:  2020-04       Impact factor: 5.128

6.  Limited Coverage of Hepatitis C Virus Testing in the United States, 2013-2017.

Authors:  Eshan U Patel; Shruti H Mehta; Denali Boon; Thomas C Quinn; David L Thomas; Aaron A R Tobian
Journal:  Clin Infect Dis       Date:  2019-04-08       Impact factor: 9.079

7.  Trends in Indicators of Injection Drug Use, Indian Health Service, 2010-2014 : A Study of Health Care Encounter Data.

Authors:  Mary E Evans; Marissa Person; Brigg Reilley; Jessica Leston; Richard Haverkate; Jeffrey T McCollum; Andria Apostolou; Michele K Bohm; Michelle Van Handel; Danae Bixler; Andrew J Mitsch; Dana L Haberling; Sarah M Hatcher; Thomas Weiser; Kim Elmore; Eyasu H Teshale; Paul J Weidle; Philip J Peters; Kate Buchacz
Journal:  Public Health Rep       Date:  2020-07-07       Impact factor: 2.792

Review 8.  Population-based screening of hepatitis C virus in the United States.

Authors:  John Bian; Andrew D Schreiner
Journal:  Curr Opin Gastroenterol       Date:  2019-05       Impact factor: 3.287

Review 9.  Addressing Hepatitis C in the American Incarcerated Population: Strategies for Nationwide Elimination.

Authors:  Selin Ocal; Andrew J Muir
Journal:  Curr HIV/AIDS Rep       Date:  2020-02       Impact factor: 5.071

10.  Contact tracing for hepatitis C: The case for novel screening strategies as we strive for viral elimination.

Authors:  Caroline Katzman; Pedro Mateu-Gelabert; Shashi N Kapadia; Benjamin J Eckhardt
Journal:  Int J Drug Policy       Date:  2019-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.